Atherosclerosis of cerebral arteries in Alzheimer disease

Stroke; a Journal of Cerebral Circulation
Alex E RoherThomas G Beach

Abstract

A growing body of evidence suggests that vascular disease underlies Alzheimer dementia. Atherosclerotic lesions in the circle of Willis and large leptomeningeal vessels were quantified and found to correlate with Alzheimer disease (AD) clinical diagnosis and neuropathology. We hypothesize that AD pathology is the complex end result of slowly evolving vascular disease and parenchymal lesions. Confirmation of a central role for vascular pathology in AD will suggest important treatment options and directions for additional interventions to stave off this dementia.

Citations

Jun 14, 2005·La Revue de médecine interne·V Antoine, A-S Rigaud
Apr 6, 2005·Trends in Neurosciences·Berislav V Zlokovic
Aug 24, 2005·Nature Medicine·Zhenhua WuBerislav V Zlokovic
Jan 29, 2010·The New England Journal of Medicine·Henry W Querfurth, Frank M LaFerla
Feb 29, 2008·Proceedings of the National Academy of Sciences of the United States of America·Eric P MeyerThomas Krucker
Nov 9, 2005·Current Opinion in Lipidology·Takashi MiidaTakeshi Ikeuchi
Dec 6, 2005·Alzheimer Disease and Associated Disorders·Helena C Chui, Margaret Gatz
Feb 24, 2006·Alzheimer Disease and Associated Disorders·Alex E RoherThomas G Beach
Mar 23, 2005·Brain Pathology·Berislav V ZlokovicJoseph M Miano
Sep 14, 2007·Neuroepidemiology·Pirjo KomulainenRainer Rauramaa
May 26, 2006·Circulation Journal : Official Journal of the Japanese Circulation Society·Masayo FukuharaTadamichi Takehara
Oct 31, 2012·Vascular Health and Risk Management·Alex E RoherThomas G Beach
Sep 2, 2006·Neurological Research·Tânia Corrêa de Toledo Ferraz Alves, Geraldo F Busatto
Sep 2, 2006·Neurological Research·Jack C de la Torre
Mar 26, 2014·Neuroscience Bulletin·Moses N WainainaChunjiu Zhong
Dec 12, 2012·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Kie HonjoNicolaas P L G Verhoeff
Mar 4, 2009·Critical Reviews in Clinical Laboratory Sciences·Jordi CampsJorge Joven
Nov 17, 2006·Expert Opinion on Investigational Drugs·James F Whitfield
Apr 27, 2010·Journal of Neuropathology and Experimental Neurology·Estifanos GhebremedhinThomas Deller
Mar 11, 2011·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Alex E RoherThomas G Beach
Mar 11, 2011·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Alex E RoherMark R Emmerling
Sep 22, 2010·Journal of the Neurological Sciences·Sandeep AnkolekarPhilip M W Bath
Mar 13, 2009·Journal of the Neurological Sciences·Alessandro StefaniMarina Diomedi
Jul 2, 2015·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Ling ZhengUNKNOWN IVD program project
Nov 11, 2008·Neurobiology of Aging·Dorothea StrozykJoe Verghese
Dec 14, 2007·Neurobiology of Aging·Mauro SilvestriniFabrizio Vernieri
Feb 5, 2008·Neurobiology of Aging·S M JanciauskieneS Warkentin
Feb 3, 2007·Neurobiology of Disease·Henrietta M NielsenSabina M Janciauskiene
May 19, 2010·Journal of Neurochemistry·Romina M UrangaJeffrey N Keller
Nov 26, 2013·Neuron·Costantino Iadecola
Nov 23, 2005·Neurobiology of Aging·Gustavo C Román, Raj N Kalaria
Dec 19, 2014·Brain Pathology·Seth Love, J Scott Miners
Jan 27, 2015·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Thomas G BeachMarwan N Sabbagh
Sep 4, 2015·Cellular and Molecular Neurobiology·Kenzo KoizumiLaibaik Park
May 15, 2015·Oxidative Medicine and Cellular Longevity·C SimonciniM Mancuso

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.